Page last updated: 2024-09-04

canertinib and rtki cpd

canertinib has been researched along with rtki cpd in 3 studies

Compound Research Comparison

Studies (canertinib)	Trials (canertinib)	Recent Studies (post-2010) (canertinib)	Studies (rtki cpd)	Trials (rtki cpd)	Recent Studies (post-2010) (rtki cpd)
124	9	65	744	0	257

Protein Interaction Comparison

Protein	Taxonomy	canertinib (IC50)	rtki cpd (IC50)
Epidermal growth factor receptor	Homo sapiens (human)		0.0584

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breza, N; Keri, G; Orfi, L; Petak, I; Pinter, F; Robert, K; Schwab, R; Varkondi, E	1
Milsom, C; Rak, J; Xing, R; Yu, JL	1
Boerner, J; Joiakim, A; Mathieu, PA; Reiners, JJ; Shelp, C	1

Reviews

1 review(s) available for canertinib and rtki cpd

Article	Year
Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1. Thrombosis research, 2010, Volume: 126, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Factor VIIa; Genes, ras; Humans; Mice; Mice, SCID; Morpholines; Neoplasms; Oncogenes; Phosphotransferases; Quinazolines; Receptor, ErbB-2; Signal Transduction; Thromboplastin; Trastuzumab; Tyrphostins; Up-Regulation	2010

Article

Year

Modulation of the oncogene-dependent tissue factor expression by kinase suppressor of ras 1.

Thrombosis research, 2010, Volume: 126, Issue:1

Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Factor VIIa; Genes, ras; Humans; Mice; Mice, SCID; Morpholines; Neoplasms; Oncogenes; Phosphotransferases; Quinazolines; Receptor, ErbB-2; Signal Transduction; Thromboplastin; Trastuzumab; Tyrphostins; Up-Regulation

2010

Other Studies

2 other study(ies) available for canertinib and rtki cpd

Article	Year
Biochemical assay-based selectivity profiling of clinically relevant kinase inhibitors on mutant forms of EGF receptor. Journal of receptor and signal transduction research, 2008, Volume: 28, Issue:3 Topics: Aminoquinolines; Aniline Compounds; Biological Assay; Drug Resistance; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Inhibitory Concentration 50; Morpholines; Mutant Proteins; Protein Kinase Inhibitors; Quinazolines; Substrate Specificity; Tyrphostins	2008
Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells. Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:5 Topics: Benzamides; Breast; Cell Line; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Drug Synergism; Epithelial Cells; ErbB Receptors; Gefitinib; Humans; MAP Kinase Kinase 1; Morpholines; Polychlorinated Dibenzodioxins; Protein Kinase Inhibitors; Quinazolines; RNA, Messenger; Tyrphostins	2016

Article

Year

Biochemical assay-based selectivity profiling of clinically relevant kinase inhibitors on mutant forms of EGF receptor.

Journal of receptor and signal transduction research, 2008, Volume: 28, Issue:3

Topics: Aminoquinolines; Aniline Compounds; Biological Assay; Drug Resistance; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Inhibitory Concentration 50; Morpholines; Mutant Proteins; Protein Kinase Inhibitors; Quinazolines; Substrate Specificity; Tyrphostins

2008

Epidermal Growth Factor Receptor Kinase Inhibitors Synergize with TCDD to Induce CYP1A1/1A2 in Human Breast Epithelial MCF10A Cells.

Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:5

Topics: Benzamides; Breast; Cell Line; Cytochrome P-450 CYP1A1; Cytochrome P-450 CYP1A2; Drug Synergism; Epithelial Cells; ErbB Receptors; Gefitinib; Humans; MAP Kinase Kinase 1; Morpholines; Polychlorinated Dibenzodioxins; Protein Kinase Inhibitors; Quinazolines; RNA, Messenger; Tyrphostins

2016